Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update [Yahoo! Finance]
Portage Biotech Inc. (PRTG)
Company Research
Source: Yahoo! Finance
Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended December 31, 2023. “The Company is focused on advancing its ADPORT-201 Phase 1a/1b clinical trial of PORT-6 (adenosine 2A inhibitor) and PORT-7 (adenosine 2B inhibitor) in selected solid tumors. The trial is progressing well with eight academic center clinical sites enrolling patients. The Phase 1a dose escalation portion of the trial has progressed to the third cohort. The Company looks forward to making a clinical update at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and presenting final data from the Phase 1a portion of ADPORT-601 (PORT-6) at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting later this year,” said Dr. Ian Walters, Chief Executive Officer and Chairman of Portage. “We are excited about futur
Show less
Read more
Impact Snapshot
Event Time:
PRTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTG alerts
High impacting Portage Biotech Inc. news events
Weekly update
A roundup of the hottest topics
PRTG
News
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesGlobeNewswire
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesGlobeNewswire
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateGlobeNewswire
PRTG
Earnings
- 8/30/23 - Miss
PRTG
Sec Filings
- 4/12/24 - Form 424B3
- 4/12/24 - Form 6-K
- 3/8/24 - Form 424B3
- PRTG's page on the SEC website